Innate Pharma (IPHA) Exchange Rate Effect (2018 - 2024)

Innate Pharma (IPHA) has reported Exchange Rate Effect for 6 consecutive years, with -$574666.9 the latest figure, recorded in Q4 2024.

• Quarterly Exchange Rate Effect changed N/A year-over-year to -$574666.9 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$2.1 million (changed N/A YoY) and the FY2025 annual result came in at $1.2 million, up 316.24% from the prior year.
• Exchange Rate Effect eased to -$574666.9 in Q4 2024 per IPHA's latest filing, from -$292454.2 in the prior quarter.
• Over the last five years, Exchange Rate Effect for IPHA reached as high as -$14793.4 in Q2 2020 and fell as low as -$762429.4 in Q2 2022.
• A 4-year average of -$411939.4 and a median of -$487044.4 in 2022 frame the typical range for Exchange Rate Effect.
• Annual changes were most pronounced in 2021 — Exchange Rate Effect tumbled 1269.23% — and 2022, when it increased 11.39%.
• Year by year, Exchange Rate Effect stood at -$14793.4 in 2020, then tumbled by 3615.38% to -$549631.9 in 2021, then grew by 11.39% to -$487044.4 in 2022, then retreated by 17.99% to -$574666.9 in 2024.
• According to Business Quant data, Exchange Rate Effect over the past three periods registered -$574666.9, -$292454.2, and -$487044.4 for Q4 2024, Q2 2024, and Q4 2022 respectively.